Loading...

Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.

China may end India's drug trade dominance

Image

05-Jul-16 India is making steady progress in the export of drugs around the world. India's Commerce & Industry Ministry said "India's pharmaceutical exports continued their lead over China in 2015." However, experts warn this trend will wane if Indian firms continue to depend on Chinese raw materials. [image: Pixabay]

Read More

China healthcare costs forcing patients into crippling debt

Image

09-Jul-16 As China's medical bills rise steeply, outpacing government insurance provision, patients and their families are increasingly turning to loans to pay for healthcare, adding to the country's growing burden of consumer debt. That is luring big companies like Ping An Insurance as well as small loan firms and P2P platforms, as China's traditional savings culture proves inadequate. [image: Reuters / David Gray]

Read More

Info-sharing, data analytics to tackle disease outbreaks in Singapore

Image

09-Jul-16 Better sharing of information and use of data will be among the tools that Singapore will use to improve its handling of infectious disease outbreaks. The Ministry of Health will also compile data from different sources and design an IT system that triggers warnings if there are abnormalities, so that investigations can begin promptly. [image: Today]

Read More

Malaysian healthcare growth driven by demographics

Image

05-Jul-16 Malaysian inpatient admissions appear finally to have turned around in the first quarter of 2016 after three consecutive quarters of decline, with IHH Healthcare Bhd up 10% year-on-year and KPJ Healthcare Bhd up 4%. The turnaround suggests that the drag on healthcare business volume from the implementation of the goods and services tax has finally worn off. [image: Bloomberg / Affin Hwang forecasts]

Read More

Report outlines reforms for China's pharmaceutical system

Image

07-Jul-16 China’s pharmaceutical system will struggle to cope with a rapidly aging population and increases in non-communicable diseases says a report by LSE Health and the State Council. The report identifies market fragmentation as a major challenge, with the top five manufacturers holding <15% market share, and finds R&D accounts for only 2% of sales, compared with 14-18% for MNC pharma companies. [image: LSE]

Read More
Share

 


0111 Banner square pre launch 250x250